Vardan Viktor Tsaturyan

Dr. Vardan Viktor Tsaturyan

Yerevan State Medical University, Yerevan, Armenia
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2022 in Cells
Verified
Journal Article
Open access
PDF file
VTVardan Viktor Tsaturyan
Vardan Viktor Tsaturyan
APArmen Poghosyan
Armen Poghosyan
MTMichał Toczyłowski
Michał Toczyłowski
APAstghik Zaven Pepoyan
Astghik Zaven Pepoyan
Either extracts, cell-free suspensions or bacterial suspensions are used to study bacterial lipid peroxidation processes. Along with gas chromatography-mass spectrometry, liquid chromatography-mass spectrometry, and several other strategies, the thiobarbituric acid test is used for the determination of malondialdehyde (MDA) as the basis for the commercial test kits and the colorimetric detection of lipid peroxidation. The aim of the current study was to evaluate lipid peroxidation processes levels in the suspensions, extracts and culture supernatants of Escherichia coli and Salmonella Derby strains. The dependence of the formation of thiobarbituric acid-reactive substances levels in the cell extracts, the suspensions and cell-free supernatants on bacterial species, and their concentration and growth phase were revealed. The effect of bacterial concentrations on MDA formation was also found to be more pronounced in bacterial suspensions than in extracts, probably due to the dynamics of MDA release into the intercellular space. This study highlights the possible importance of MDA determination in both cell-free suspensions and extracts, as well as in bacterial suspensions to elucidate the role of lipid peroxidation processes in bacterial physiology, bacteria–host interactions, as well as in host physiology.

26 June 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
APAstghik Zaven Pepoyan
Astghik Zaven Pepoyan
MBMarine Balayan
Marine Balayan
AMAnahit Manvelyan
Anahit Manvelyan
LGLilit Galstyan
Lilit Galstyan
SPSofi Pepoyan
Sofi Pepoyan
MCMichael Chikindas
Michael Chikindas
Intestinal microorganisms play a crucial role in health and disease. The disruption of host –microbiota homeostasis has been reported to occur not only during disease development, but also as a result of medication. Familial Mediterranean fever (FMF) is an inflammatory genetic disease characterized by elevated systemic reactivity against the commensal gut microbiota and high levels of Candida albicans in the gut. This study’s major objective was to investigate the effects of commercial probiotic Narine on the relative abundance of gut bacteria (specifically, enterobacteria, lactobacilli, Staphylococcus aureus, and enterococci) of Candida albicans carrier and non-carrier FMF patients in remission. Our main finding indicates that the probiotic reduces numbers of C. albicans and abundance of enterobacteria in male and female patients of C. albicans carriers and non-carriers. It has pivotal effect on Enterococcus faecalis: increase in male non-carriers and decrease in female ones regardless of C. albicans status. No effect was seen for Lactobacillus and S. aureus. Our data suggest that M694V/V726A pyrin inflammasome mutations leading to FMF disease may contribute to gender specific differences in microbial community structure in FMF patients. The study’s secondary objective was to elucidate the gender-specific differences in the gut’s microbial community of FMF patients. The tendency was detected for higher counts of enterobacteria in female FMF subjects. However, the small number of patients of these groups preclude from conclusive statements, pointing at the need for additional investigations with appropriate for statistical analysis groups of subjects involved in the study.

2 February 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ZLZachery T Lewis
Zachery T Lewis
KSKetevan Sidamonidze
Ketevan Sidamonidze
VTVardan Viktor Tsaturyan
Vardan Viktor Tsaturyan
DTDavid Tsereteli
David Tsereteli
NKNika Khachidze
Nika Khachidze
DMDavid A Mills
David A Mills
Multiple factors help shape the infant intestinal microbiota early in life. Environmental conditions such as the presence of bioactive molecules from breast milk dictate gut microbial growth and survival. Infants also receive distinct, personalized, bacterial exposures leading to differential colonization. Microbial exposures and gut environmental conditions differ between infants in different locations, as does the typical microbial community structure in an infant’s gut. Here we evaluate potential influences on the infant gut microbiota through a longitudinal study on cohorts of breast-fed infants from the neighboring countries of Armenia and Georgia, an area of the world for which the infant microbiome has not been previously investigated. Marker gene sequencing of 16S ribosomal genes revealed that the gut microbial communities of infants from these countries were dominated by bifidobacteria, were different from each other, and were marginally influenced by their mother’s secretor status. Species-level differences in the bifidobacterial communities of each country and birth method were also observed. These community differences suggest that environmental variation between individuals in different locations may influence the gut microbiota of infants.

27 May 2020 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Closed access
PDF file
APAstghik Zaven Pepoyan
Astghik Zaven Pepoyan
AMAnahit M. Manvelyan
Anahit M. Manvelyan
MBMarine H. Balayan
Marine H. Balayan
GMGavin McCabe
Gavin McCabe
VTVardan Viktor Tsaturyan
Vardan Viktor Tsaturyan
Andrey V. KarlyshevAndrey V. Karlyshev
Andrey V. Karlyshev

1 April 2017 in Letters in Applied Microbiology
Verified
Journal Article
Closed access
PDF file
APAstghik Zaven Pepoyan
Astghik Zaven Pepoyan
MBM.H. Balayan
M.H. Balayan
AMA.M. Manvelyan
A.M. Manvelyan
VMV. Mamikonyan
V. Mamikonyan
MIM. Isajanyan
M. Isajanyan
Michael Leonidas ChikindasMichael Leonidas Chikindas
Michael Leonidas Chikindas

19 June 2019 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Closed access
PDF file
APAstghik Zaven Pepoyan
Astghik Zaven Pepoyan
AMAnahit M. Manvelyan
Anahit M. Manvelyan
MBMarine H. Balayan
Marine H. Balayan
SGSamvel Galstyan
Samvel Galstyan
VTVardan Viktor Tsaturyan
Vardan Viktor Tsaturyan
MCMichael L. Chikindas
Michael L. Chikindas